Michael Scolaro

Michael Scolaro

Aug 27, 2017

Group 6 Copy 47
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    You have mail: Stem Cell messages for fighting liver diseases

    The use of stem cells is currently limited by issues including the risk of tumor formation or undesired...

    Can we make anesthesia for dogs safer with the help of nutrition?

    Hypothermia, low body temperature, is one of the most common complications of anesthesia and can result...

    Decreasing the Risk of Death and Diving Injuries in Artisanal Fishermen

    Artisanal fishermen risk their lives every day to support their families and communities. Using outdated...

    Backer Badge Funded